Package 71610-637-45

Brand: pravastatin sodium

Generic: pravastatin sodium
NDC Package

Package Facts

Identity

Package NDC 71610-637-45
Digits Only 7161063745
Product NDC 71610-637
Description

45 TABLET in 1 BOTTLE (71610-637-45)

Marketing

Marketing Status
Marketed Since 2022-02-24
Brand pravastatin sodium
Generic pravastatin sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5d082e37-f27a-4be2-bf4c-8e1c5bb976af", "openfda": {"unii": ["3M8608UQ61"], "rxcui": ["904481"], "spl_set_id": ["ce61f570-2564-429b-8775-157e8e32d378"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-637-30)", "package_ndc": "71610-637-30", "marketing_start_date": "20220224"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (71610-637-45)", "package_ndc": "71610-637-45", "marketing_start_date": "20220224"}], "brand_name": "PRAVASTATIN SODIUM", "product_id": "71610-637_5d082e37-f27a-4be2-bf4c-8e1c5bb976af", "dosage_form": "TABLET", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "71610-637", "generic_name": "PRAVASTATIN SODIUM", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PRAVASTATIN SODIUM", "active_ingredients": [{"name": "PRAVASTATIN SODIUM", "strength": "80 mg/1"}], "application_number": "ANDA076341", "marketing_category": "ANDA", "marketing_start_date": "20110718", "listing_expiration_date": "20261231"}